Sutherland, Rachel and Karlsson, Antonia and King, Cate and Jones, Fiona and Uporova, Julia and Price, Olivia and Gibbs, Daisy and Bruno, Raimondo and Dietze, Paul and Lenton, Simon R and Salom, Caroline and Grigg, Jodie and Wilson, Yalei and Wilson, Joanna and Daly, Catherine and Thomas, Natalie and Juckel, Jennifer and Degenhardt, Louisa and Farrell, Michael and Peacock, Amy (2022) Australian drug trends 2022: key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.
| Preview | Title | Contact |
|---|---|---|
|
PDF (National Ecstasy and Related Drugs Reporting System 2022 report)
3MB | |
|
PDF (National Ecstasy and Related Drugs Reporting System 2022 Executive summary)
118kB |
The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has been conducted in all states and territories of Australia since 2003, and forms part of Drug Trends.
In 2022, we have provided a suite of products with the most up-to-date findings from interviews conducted annually from 2003 to 2022 with a cross-sectional sentinel group of people who regularly use ecstasy and other stimulants recruited from all capital cities of Australia. This includes:
- A report overviewing the key findings in 2022;
- An infographic summarising key findings in 2022;
- A methods document highlighting approaches to collating and presenting estimates; and
- The executive summary, summarising key findings in 2022.
Results are not representative of all consumers or drug use in the general population and should be interpreted alongside findings from other data sources for a more complete profile of emerging trends in illicit drug use in Australia.
Repository Staff Only: item control page